Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$12.78 - $17.4 $49.5 Million - $67.4 Million
-3,875,000 Reduced 62.25%
2,350,000 $38.2 Million
Q1 2024

May 10, 2024

BUY
$10.67 - $14.43 $61.2 Million - $82.8 Million
5,735,000 Added 1170.41%
6,225,000 $87.8 Million
Q4 2023

Feb 09, 2024

SELL
$8.12 - $10.63 $10.6 Million - $13.9 Million
-1,306,600 Reduced 72.73%
490,000 $5.12 Million
Q3 2023

Nov 09, 2023

SELL
$7.48 - $10.7 $3.74 Million - $5.35 Million
-500,000 Reduced 21.77%
1,796,600 $18.3 Million
Q2 2023

Aug 10, 2023

SELL
$7.2 - $9.47 $67.6 Million - $88.9 Million
-9,391,200 Reduced 80.35%
2,296,600 $17.3 Million
Q1 2023

May 11, 2023

BUY
$8.36 - $11.37 $25.3 Million - $34.4 Million
3,029,000 Added 34.98%
11,687,800 $103 Million
Q4 2022

Feb 09, 2023

BUY
$7.95 - $9.48 $11.6 Million - $13.8 Million
1,456,600 Added 20.22%
8,658,800 $79 Million
Q3 2022

Nov 10, 2022

SELL
$6.86 - $11.95 $4.8 Million - $8.36 Million
-700,000 Reduced 8.86%
7,202,200 $58.1 Million
Q2 2022

Aug 10, 2022

SELL
$7.38 - $10.4 $2.16 Million - $3.05 Million
-292,800 Reduced 3.57%
7,902,200 $59.4 Million
Q1 2022

May 12, 2022

SELL
$7.33 - $9.39 $24 Million - $30.8 Million
-3,279,000 Reduced 28.58%
8,195,000 $77 Million
Q4 2021

Feb 10, 2022

BUY
$7.9 - $10.19 $76.9 Million - $99.2 Million
9,734,700 Added 559.69%
11,474,000 $91.9 Million
Q3 2021

Nov 10, 2021

BUY
$8.38 - $10.18 $14.6 Million - $17.7 Million
1,739,300 New
1,739,300 $16.9 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.